PCT & Support

Chorionic Gonadotropin Injection IP EUTRIG-HP 2000 IU Samarth

IU Samarth

60,00

In Stock (100 available)

Chorionic Gonadotropin Injection IP EUTRIG-HP 2000 IU Samarth (2000 iu) — IU Samarth presents this pharmaceutical-grade compound — essential for maintaining testicular function and size during anabolic …

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

Chorionic Gonadotropin Injection IP EUTRIG-HP 2000 IU Samarth — human chorionic gonadotropin from Samarth at 2000 iu. LH-mimetic: directly stimulates leydig-cell testosterone production and spermatogenesis. On-cycle testicular maintenance or pre-PCT priming.

Key Benefits

  • Human chorionic gonadotropin — mimics LH, stimulates testicular testosterone
  • Prevents testicular atrophy on long cycles
  • Used on-cycle (not during PCT — can desensitise receptors)
  • Reconstituted with bacteriostatic water; SubQ or IM injection
  • Standard on-cycle 250–500 IU 2× weekly
  • Each unit dosed at 2000 IU — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: on-cycle 250–500 IU 2× weekly SubQ to prevent testicular atrophy. Pre-PCT blast 1000 IU 2× weekly for 2 weeks. Not used during PCT proper — chronic HCG desensitises Leydig cells to LH.

How It Works

Human chorionic gonadotropin, a glycoprotein hormone with LH-like activity. Binds the LH receptor on testicular Leydig cells, stimulating testosterone production directly — bypasses pituitary suppression.

Pharmacokinetics

Plasma half-life approximately 33 hours. Twice-weekly SubQ dosing produces stable effect. Reconstituted vial stable in fridge for 30 days.

Potential Side Effects

Excessive dose raises E2 (testicular estrogen output) — pair with AI. Water retention possible. Chronic high-dose use desensitises LH receptors, hampering natural recovery.

Cycle & Stacking Guide

On-cycle protocol: 500 IU 2× weekly throughout the cycle to maintain testicular size and function. Stop 2 weeks before SERM-based PCT begins. Alternative: pre-PCT blast approach — skip during cycle, then 1000 IU × 2/week for 2 weeks before starting SERMs.

Manufacturer Notes

Samarth is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.

Storage & Handling

Pre-reconstitution: store at 2–8 °C, protected from freezing and light. Post-reconstitution: use within 14–21 days, maintained at 2–8 °C throughout. Never freeze reconstituted solution — freezing irreversibly denatures the protein. Transport in an insulated cold-pack for trips. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Chorionic Gonadotropin Injection IP EUTRIG-HP 2000 IU Samarth”

Your email address will not be published. Required fields are marked *

Human Chorionic Gonadotropin

Physical & Chemical Properties for Research Purposes
Chemical structure of Human Chorionic Gonadotropin (Glycoprotein (~37 kDa)) for laboratory analysis
2D structural representation · PubChem CID 56841945 ↗
Chemical Identity
# CAS Registry Number 9002-61-3
Σ IUPAC Name Human chorionic gonadotropin (glycoprotein hormone, alpha/beta subunit dimer)
F Molecular Formula Glycoprotein (~37 kDa)
M Molecular Weight 36700 g/mol
Melting Point N/A (glycoprotein) °C
Solubility Soluble in water (lyophilized powder reconstituted with bacteriostatic water)
Biological Half-life 24-36 hours (IM/SC)
PubChem CID 56841945 ↗
Pharmacological Profile
Aromatization None
Hepatotoxicity None
Known trade names: Pregnyl, Ovidrel, Novarel, Choragon

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.